
Onbort 3.5mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Bortezomib (3.5mg)
Overview Onbort 3.5mg Injection
Bortezomib 3.5mg injection treats multiple myeloma and mantle cell lymphoma by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, requiring several weeks or months; discontinue only under medical supervision. Common side effects include fatigue, nausea, vomiting, and anorexia. Increased fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication may suppress blood cell production (reducing red and white blood cells), increasing infection risk. Regular blood tests monitoring blood counts, along with heart, liver function, and uric acid levels, are essential. Pre-existing liver, kidney, heart conditions, or bleeding disorders necessitate prior consultation. Report cognitive symptoms like memory impairment or difficulty concentrating to your doctor. Inform your healthcare provider of all other medications you are taking due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is advised for both partners throughout the treatment period.
Primary Ingredients of Onbort 3.5mg Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Onbort 3.5mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Onbort 3.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Onbort 3.5mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Onbort 3.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Onbort 3.5mg Injection works:
Onbort 3.5mg Injection, an anticancer agent, inhibits the cellular degradation of proteins. This protein accumulation within cancer cells subsequently triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Onbort 3.5mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Onbort 3.5mg Injection during pregnancy is contraindicated due to confirmed harm to the fetus. Exceptions may exist in critical circumstances where the physician deems the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Onbort 3.5mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Onbort 3.5mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially impairing driving safety.
KidneyCAUTION
The administration of Onbort 3.5mg Injection requires careful consideration in individuals suffering from advanced kidney impairment. A modified dosage of Onbort 3.5mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Onbort 3.5mg Injection requires careful administration in individuals with hepatic impairment. Dosage modification of Onbort 3.5mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Onbort 3.5mg Injection :
Omit a dose of Onbort 3.5mg Injection? Seek your physician's advice.
Facts to Know About Onbort 3.5mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Phenylalanine-Based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
